{Reference Type}: Journal Article
{Title}: Role of LMO7 in cancer (Review).
{Author}: Zeng Q;Jiang T;Wang J;
{Journal}: Oncol Rep
{Volume}: 52
{Issue}: 3
{Year}: 2024 09
{Factor}: 4.136
{DOI}: 10.3892/or.2024.8776
{Abstract}: Cancer constitutes a multifaceted ailment characterized by the dysregulation of numerous genes and pathways. Among these, LIM domain only 7 (LMO7) has emerged as a significant player in various cancer types, garnering substantial attention for its involvement in tumorigenesis and cancer progression. This review endeavors to furnish a comprehensive discourse on the functional intricacies and mechanisms of LMO7 in cancer, with a particular emphasis on its potential as both a therapeutic target and prognostic indicator. It delves into the molecular attributes of LMO7, its implications in cancer etiology and the underlying mechanisms propelling its oncogenic properties. Furthermore, it underscores the extant challenges and forthcoming prospects in targeting LMO7 for combating cancer.